Fig. 1.

Pathogens complexity increases with size. Soluble toxins can be blocked by inhibiting the active site, and a single mAb can also neutralize a virus conferring protection. However, larger bacteria or more complex parasites require engagement of multiple effector functions to be destroyed, thus increasing the difficulty to be treated by single monoclonal antibodies.